A clinicopathological study of nodal marginal zone B-cell lymphoma. A report on 21 cases

Aims : To report the clinicopathological findings of 21 cases of primary nodal marginal zone B‐cell lymphoma (NMZL). NMZL is a recently characterized lymphoma and few series have been published. Methods and results : The clinical data were characteristic of a disseminated disease at presentation: pr...

Full description

Saved in:
Bibliographic Details
Published inHistopathology Vol. 48; no. 2; pp. 162 - 173
Main Authors Traverse-Glehen, A, Felman, P, Callet-Bauchu, E, Gazzo, S, Baseggio, L, Bryon, P A, Thieblemont, C, Coiffier, B, Salles, G, Berger, F
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Science Ltd 01.01.2006
Blackwell
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Aims : To report the clinicopathological findings of 21 cases of primary nodal marginal zone B‐cell lymphoma (NMZL). NMZL is a recently characterized lymphoma and few series have been published. Methods and results : The clinical data were characteristic of a disseminated disease at presentation: presence of peripheral and abdominal lymph nodes, bone marrow involvement (62%), disease stage III and IV (76%), elevated lactate dehydrogenase (LDH) (48%). Other features included peripheral blood involvement (23%), anaemia (24%), thrombocytopenia (10%) and presence of serum M component (33%), while the previously reported association with hepatitis C virus and cryoglobulinaemia was not found. Relapses were frequent but the majority of patients receiving chemotherapy had a good initial response. Morphological features were heterogeneous and there were some differences compared with other marginal zone B‐cell lymphomas (MZL). Pure monocytoid B‐cell lymphomas were rare (10%) but a minor component of monocytoid B cell was observed more frequently (23%). Plasmacytoid or plasmacytic differentiation was a very common feature (61%). Large cells and a high mitotic count were also frequent (57%). Conclusion : NMZL can be distinguished from splenic MZL and extranodal MZL by its aggressive morphology and disseminated disease at presentation.
Bibliography:ark:/67375/WNG-R396R9TV-N
istex:95B1CC79EDBB6CCBF7B9514857B8C30E4CBE204E
ArticleID:HIS2309
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0309-0167
1365-2559
DOI:10.1111/j.1365-2559.2005.02309.x